Clinical Trial Update: Pharmacokinetic Study of Sudapyridine（WX-081）in Healthy Chinese Subjects [Phase 1]

View source ↗

Summary

This is a Phase 1 pharmacokinetic study of sudapyridine (WX-081) in healthy Chinese subjects to characterize its PK profile for tuberculosis therapy. The study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• WX-081 (Sudapyridine) (Sudapyridine)

Snippet

Sponsor: Shanghai Jiatan Pharmatech Co., Ltd | Conditions: TB | Phase 1 | Status: RECRUITING